← Leaderboards
Shivanand P Lad
Duke University
$6,643,782
Attributed
$10,153,261
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,153,261 · 7
VA$0 · 1
By mechanism
R42$6,344,095 · 3
UH3$3,134,303 · 1
R41$674,863 · 3
I01$0 · 1
Top collaborators
- Aaron Richard Mccabe11 shared
Most similar at Duke University
Same institution · by research overlap
- Dorothy A Sipkins$8,543,606
- Darell D Bigner$25,397,506
- Bryan Choi$684,499
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationDevicesProceduresStandard Of CareSpinalSamplingCollaborationsNeurosurgeryUniversitiesAffectSpinal CordQuality Of LifeElementsClinical ResearchExcisionOryctolagus CuniculusBlood CirculationIn VivoIn VitroFiltrationMedical DeviceMorbidity - Disease RateDesignCerebrospinal Fluid
Grant awards (20)
A Double-Blind, Randomized, Controlled Trial of Epidural Conus Medullaris Stimulation to Alleviate Pain and Augment Rehabilitation in Patients with Subacute Thoracic Spinal Cord Injury (SCI)$586,419
UH3 · FY2025 · NS · contact PI
A Double-Blind, Randomized, Controlled Trial of Epidural Conus Medullaris Stimulation to Alleviate Pain and Augment Rehabilitation in Patients with Subacute Thoracic Spinal Cord Injury (SCI)$890,930
UH3 · FY2024 · NS · contact PI
A Double-Blind, Randomized, Controlled Trial of Epidural Conus Medullaris Stimulation to Alleviate Pain and Augment Rehabilitation in Patients with Subacute Thoracic Spinal Cord Injury (SCI)$917,817
UH3 · FY2023 · NS · contact PI
Evaluation of Efficiency and Selectivity of a Novel Computational Model of Spinal Cord Stimulation for Chronic Pain$0
I01 · FY2021 · VA · contact PI
Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis$939,151
R42 · FY2020 · AI
A Double-Blind, Randomized, Controlled Trial of Epidural Conus Medullaris Stimulation to Alleviate Pain and Augment Rehabilitation in Patients with Subacute Thoracic Spinal Cord Injury (SCI)$739,137
UH3 · FY2020 · NS · contact PI
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases$637,111
R42 · FY2020 · CA
Evaluation of Efficiency and Selectivity of a Novel Computational Model of Spinal Cord Stimulation for Chronic Pain$0
I01 · FY2020 · VA · contact PI
Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis$970,147
R42 · FY2019 · AI
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases$646,349
R42 · FY2019 · CA
Evaluation of Efficiency and Selectivity of a Novel Computational Model of Spinal Cord Stimulation for Chronic Pain$0
I01 · FY2019 · VA · contact PI
Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis$998,500
R42 · FY2018 · AI
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases$665,919
R42 · FY2018 · CA
Validation of Novel Therapeutic Approach for Cryptococcal Meningitis$486,918
R42 · FY2018 · AI
Evaluation of Efficiency and Selectivity of a Novel Computational Model of Spinal Cord Stimulation for Chronic Pain$0
I01 · FY2018 · VA · contact PI
Validation of Novel Therapeutic Approach for Cryptococcal Meningitis$1,000,000
R42 · FY2017 · AI
Evaluation of Efficiency and Selectivity of a Novel Computational Model of Spinal Cord Stimulation for Chronic Pain$0
I01 · FY2017 · VA · contact PI
Directed Chemotherapy Delivery for Leptomeningeal Metastases$224,970
R41 · FY2016 · CA
Directed Antifungal Therapy for HIV-associated Cryptococcal Meningitis$224,976
R41 · FY2015 · AI
Development of a Novel Therapeutic Approach for Cryptococcal Meningitis$224,917
R41 · FY2015 · AI